Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
The efficacy of continuing osimertinib with platinum pemetrexed chemotherapy upon progression in patients with metastatic non-small cell lung cancer harboring sensitizing EGFR mutations.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: July 31, 2024
The Efficacy and Safety of Treating Acquired MET Resistance Through Combinations of Parent and MET Tyrosine Kinase Inhibitors in Patients With Metastatic Oncogene-Driven NSCLC.
Journal: JTO clinical and research reports
Published: September 11, 2023
Sugemalimab, a novel PD-L1 inhibitor for treatment of advanced or metastatic non-small cell lung cancer.
Journal: Drugs of today (Barcelona, Spain : 1998)
Published: February 27, 2023
MET alterations in advanced non-small cell lung cancer.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: December 13, 2022
New Persistent Opioid and Benzodiazepine Use After Curative-Intent Treatment in Patients With Breast Cancer.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: February 20, 2020
Lorlatinib Salvages CNS Relapse in an ALK-Positive Non-Small-Cell Lung Cancer Patient Previously Treated With Crizotinib and High-Dose Brigatinib.
Journal: Clinical lung cancer
Published: July 26, 2018
Showing 1-8 of 8
Last Updated: 09/26/2026